The immunohistochemical expression of Beclin-1 has been detected, in fact, in about 100% of benign nevi and 86.4% of dysplastic nevi, decreasing to 54.3% in primary melanomas and up to 26.7% in melanoma metastases. The gene discussed is BECN1; the disease is dysplastic nevus.